ID: ALA420451

Max Phase: Preclinical

Molecular Formula: C12H11NO3S

Molecular Weight: 249.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(c1ccccc1)N(O)c1ccccc1

Standard InChI:  InChI=1S/C12H11NO3S/c14-13(11-7-3-1-4-8-11)17(15,16)12-9-5-2-6-10-12/h1-10,14H

Standard InChI Key:  GIRGWRZFFZOIBR-UHFFFAOYSA-N

Associated Targets(non-human)

Aldehyde dehydrogenase 1A1 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.29Molecular Weight (Monoisotopic): 249.0460AlogP: 2.27#Rotatable Bonds: 3
Polar Surface Area: 57.61Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.54CX Basic pKa: CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.85Np Likeness Score: -0.87

References

1. Conway TT, DeMaster EG, Lee MJ, Nagasawa HT..  (1998)  Prodrugs of nitroxyl and nitrosobenzene as cascade latentiated inhibitors of aldehyde dehydrogenase.,  41  (15): [PMID:9667978] [10.1021/jm980200+]

Source